These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-tumour activity of aminopterin-monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate-monoclonal antibody conjugates. Kanellos J, Pietersz GA, Cunningham Z, McKenzie IF. Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():483-93. PubMed ID: 3502340 [Abstract] [Full Text] [Related]
3. Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary. Pietersz GA, Cunningham Z, McKenzie IF. Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():43-9. PubMed ID: 3372005 [Abstract] [Full Text] [Related]
11. In vivo studies of whole ricin monoclonal antibody immunoconjugates for the treatment of murine tumours. Kanellos J, MacKenzie IF, Pietersz GA. Immunol Cell Biol; 1988 Aug; 66 ( Pt 5-6)():403-15. PubMed ID: 3265693 [Abstract] [Full Text] [Related]
12. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor. Deguchi T, Chu TM, Leong SS, Horoszewicz JS, Lee CL. Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053 [Abstract] [Full Text] [Related]
13. Studies on the mechanism of action of an MTX-HSA-MoAb conjugate. Fitzpatrick JJ, Garnett MC. Anticancer Drug Des; 1995 Jan; 10(1):11-24. PubMed ID: 7695811 [Abstract] [Full Text] [Related]
14. Poly(L-lysine) has different membrane transport and drug-carrier properties when complexed with heparin. Shen WC, Ryser HJ. Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7589-93. PubMed ID: 6950400 [Abstract] [Full Text] [Related]
15. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates. Pietersz GA, Smyth MJ, McKenzie IF. Cancer Res; 1988 Feb 15; 48(4):926-31. PubMed ID: 3422182 [Abstract] [Full Text] [Related]
16. Monensin is obligatory for the cytotoxic action of a disulfide linked methotrexate-anti-transferrin receptor conjugate. Raso V, Fehrmann C, Solan VC, Rosowsky A. Biochem Biophys Res Commun; 1988 Jan 15; 150(1):104-10. PubMed ID: 3276306 [Abstract] [Full Text] [Related]
17. The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3. Rowland AJ, Harper ME, Wilson DW, Griffiths K. Br J Cancer; 1990 May 15; 61(5):702-8. PubMed ID: 2337507 [Abstract] [Full Text] [Related]
18. Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates. Smyth MJ, Foster HM, Andrew SM, Teh JG, Krauer K, McKenzie IF, Pietersz GA. Immunol Cell Biol; 1993 Jun 15; 71 ( Pt 3)():167-79. PubMed ID: 8349300 [Abstract] [Full Text] [Related]
19. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines. Affleck K, Embleton MJ. Br J Cancer; 1992 Jun 15; 65(6):838-44. PubMed ID: 1616855 [Abstract] [Full Text] [Related]
20. Hydrolysis of methotrexate-immunoglobulin conjugates by liver homogenates and characterization of catabolites. Uadia PO, Blair AH, Ghose T. Cancer Chemother Pharmacol; 1988 Jun 15; 22(2):175-7. PubMed ID: 3409449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]